{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T22:28:17Z","timestamp":1771540097060,"version":"3.50.1"},"reference-count":48,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,7,28]],"date-time":"2021-07-28T00:00:00Z","timestamp":1627430400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>For the zoonotic disease Q fever, serological analysis plays a dominant role in the diagnosis of<jats:italic>Coxiella burnetii<\/jats:italic>infection and in pre-screening for past exposure prior to vaccination. A number of studies suggest that assessment of<jats:italic>C. burnetii<\/jats:italic>-specific T-cell IFN\u03b3 responses may be a more sensitive tool to assess past exposure. In this study, we assessed the performance of a whole blood<jats:italic>C. burnetii<\/jats:italic>IFN\u03b3 release assay in comparison to serological detection in an area of high Q fever incidence in 2014, up to seven years after initial exposure during the Dutch Q fever outbreak 2007-2010. In a cohort of &amp;gt;1500 individuals from the Dutch outbreak village of Herpen, approximately 60% had mounted IFN\u03b3 responses to<jats:italic>C. burnetii<\/jats:italic>. This proportion was independent of the<jats:italic>Coxiella<\/jats:italic>strain used for stimulation and much higher than the proportion of individuals scored sero-positive using the serological gold standard immunofluorescence assay. Moreover,<jats:italic>C. burnetii<\/jats:italic>-specific IFN\u03b3 responses were found to be more durable than antibody responses in two sub-groups of individuals known to have sero-converted as of 2007 or previously reported to the municipality as notified Q fever cases. A novel ready-to-use version of the IFN\u03b3 release assay assessed in a subgroup of pre-exposed individuals in 2021 (10-14 years post exposure) proved again to be more sensitive than serology in detecting past exposure. These data demonstrate that<jats:italic>C. burnetii<\/jats:italic>-induced IFN\u03b3 release is indeed a more sensitive and durable marker of exposure to<jats:italic>C. burnetii<\/jats:italic>than are serological responses. In combination with a simplified assay version suitable for implementation in routine diagnostic settings, this makes the assessment of IFN\u03b3 responses a valuable tool for exposure screening to obtain epidemiological data, and to identify previously exposed individuals in pre-vaccination screens.<\/jats:p>","DOI":"10.3389\/fimmu.2021.701811","type":"journal-article","created":{"date-parts":[[2021,7,28]],"date-time":"2021-07-28T13:27:16Z","timestamp":1627478836000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Whole Blood Interferon \u03b3 Release Is a More Sensitive Marker of Prior Exposure to Coxiella burnetii Than Are Antibody Responses"],"prefix":"10.3389","volume":"12","author":[{"given":"Anja","family":"Scholzen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margot","family":"de Vries","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans-Peter","family":"Duerr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hendrik-Jan","family":"Roest","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann E.","family":"Sluder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark C.","family":"Poznansky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milou L. C. E.","family":"Kouwijzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anja","family":"Garritsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,7,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00045-16","article-title":"From Q Fever to Coxiella Burnetii Infection: A Paradigm Change","volume":"30","author":"Eldin","year":"2017","journal-title":"Clin Microbiol Rev"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268812001203","article-title":"Screening for Coxiella Burnetii Seroprevalence in Chronic Q Fever High-Risk Groups Reveals the Magnitude of the Dutch Q Fever Outbreak","volume":"141","author":"Kampschreur","year":"2013","journal-title":"Epidemiol Infect"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00185-12","article-title":"Prevalence of Chronic Q Fever in Patients With a History of Cardiac Valve Surgery in an Area Where Coxiella Burnetii is Epidemic","volume":"19","author":"Kampschreur","year":"2012","journal-title":"Clin Vaccine Immunol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0155884","article-title":"Fatigue Following Acute Q-Fever: A Systematic Literature Review","volume":"11","author":"Morroy","year":"2016","journal-title":"PloS One"},{"key":"B5","article-title":"Economische Gevolgen Van De Uitbraak Van Qkoorts","volume":"15","author":"Tempelman","year":"2011","journal-title":"Amsterdam: SEO"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1071\/NB07057","article-title":"A Review of the Efficacy of Human Q Fever Vaccine Registered in Australia","volume":"18","author":"Chiu","year":"2007","journal-title":"N S W Public Health Bull"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1467-842X.2001.tb00595.x","article-title":"Abattoir-Associated Q Fever: A Q Fever Outbreak During a Q Fever Vaccination Program","volume":"25","author":"Gilroy","year":"2001","journal-title":"Aust N Z J Public Health"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2017.10.088","article-title":"Q-Vax Q Fever Vaccine Failures, Victoria, Australia 1994-2013","volume":"35","author":"Bond","year":"2017","journal-title":"Vaccine"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268800059458","article-title":"Vaccine Prophylaxis of Abattoir-Associated Q Fever: Eight Years\u2019 Experience in Australian Abattoirs","volume":"104","author":"Marmion","year":"1990","journal-title":"Epidemiol Infect"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00454-09","article-title":"Real-Time PCR With Serum Samples Is Indispensable for Early Diagnosis of Acute Q Fever","volume":"17","author":"Schneeberger","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3201\/eid2107.130955","article-title":"Chronic Q Fever Diagnosis- Consensus Guideline Versus Expert Opinion","volume":"21","author":"Kampschreur","year":"2015","journal-title":"Emerg Infect Dis"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.05581-11","article-title":"Evaluation of Commonly Used Serological Tests for Detection of Coxiella Burnetii Antibodies in Well-Defined Acute and Follow-Up Sera","volume":"19","author":"Wegdam-Blans","year":"2012","journal-title":"Clin Vaccine Immunol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-014-2048-4","article-title":"Serology in Chronic Q Fever Is Still Surrounded by Question Marks","volume":"33","author":"Wegdam-Blans","year":"2014","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cir132","article-title":"Chronic Q Fever: Different Serological Results in Three Countries\u2013Results of a Follow-Up Study 6 Years After a Point Source Outbreak","volume":"52","author":"Healy","year":"2011","journal-title":"Clin Infect Dis"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2009.09.010","article-title":"Difficulties in the Diagnosis and Management of a US Servicemember Presenting With Possible Chronic Q Fever","volume":"60","author":"Ake","year":"2010","journal-title":"J Infect"},{"key":"B16","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1017\/S0950268812000404","article-title":"Time-Course of Antibody Responses Against Coxiella Burnetii Following Acute Q Fever","volume":"141","author":"Teunis","year":"2013","journal-title":"Epidemiol Infect"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/hcs119","article-title":"An Analysis of Q Fever Patients 6 Years After an Outbreak in Newport, Wales, UK","volume":"105","author":"Hussain-Yusuf","year":"2012","journal-title":"QJM"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2014.00726","article-title":"Vaccination Against Q Fever for Biodefense and Public Health Indications","volume":"5","author":"Ruiz","year":"2014","journal-title":"Front Microbiol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2014.09.061","article-title":"Adverse Events and Association With Age, Sex and Immunological Parameters of Q Fever Vaccination in Patients at Risk for Chronic Q Fever in the Netherlands 2011","volume":"32","author":"Schoffelen","year":"2014","journal-title":"Vaccine"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1111\/j.1467-842X.2005.tb00749.x","article-title":"Control Strategies for Q Fever Based on Results of Pre-Vaccination Screening in Victoria, 1988 to 2001","volume":"29","author":"Greig","year":"2005","journal-title":"Aust NZ J Public Health"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines6040083","article-title":"Frequency of Adverse Events Following Q Fever Immunisation in Young Adults","volume":"6","author":"Sellens","year":"2018","journal-title":"Vaccines (Basel)"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cit129","article-title":"Specific Interferon Gamma Detection for the Diagnosis of Previous Q Fever","volume":"56","author":"Schoffelen","year":"2013","journal-title":"Clin Infect Dis"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2013.08.008","article-title":"Limited Humoral and Cellular Responses to Q Fever Vaccination in Older Adults With Risk Factors for Chronic Q Fever","volume":"67","author":"Schoffelen","year":"2013","journal-title":"J Infect"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268815002472","article-title":"The Health Status of a Village Population, 7 Years After a Major Q Fever Outbreak","volume":"144","author":"Morroy","year":"2016","journal-title":"Epidemiol Infect"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0131777","article-title":"Population Screening for Chronic Q-Fever Seven Years After a Major Outbreak","volume":"10","author":"Morroy","year":"2015","journal-title":"PloS One"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268808001908","article-title":"Investigation of a Q Fever Outbreak in a Rural Area of The Netherlands","volume":"137","author":"Karagiannis","year":"2009","journal-title":"Epidemiol Infect"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0931379100","article-title":"Complete Genome Sequence of the Q-Fever Pathogen Coxiella Burnetii","volume":"100","author":"Seshadri","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1128\/genomeA.00245-16","article-title":"First Complete Genome Sequence of the Dutch Veterinary Coxiella Burnetii Strain Nl3262, Originating From the Largest Global Q Fever Outbreak, and Draft Genome Sequence of Its Epidemiologically Linked Chronic Human Isolate Nlhu3345937","volume":"4","author":"Kuley","year":"2016","journal-title":"Genome Announc"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3201\/eid1704.101562","article-title":"Molecular Epidemiology of Coxiella Burnetii From Ruminants in Q Fever Outbreak, the Netherlands","volume":"17","author":"Roest","year":"2011","journal-title":"Emerg Infect Dis"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0812074106","article-title":"Host Cell-Free Growth of the Q Fever Bacterium Coxiella burnetii","volume":"106","author":"Omsland","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1128\/AEM.02826-10","article-title":"Isolation From Animal Tissue and Genetic Transformation of Coxiella burnetii Are Facilitated by an Improved Axenic Growth Medium","volume":"77","author":"Omsland","year":"2011","journal-title":"Appl Environ Microbiol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1007\/978-94-007-4315-1_11","article-title":"Axenic Growth of Coxiella burnetii","volume":"984","author":"Omsland","year":"2012","journal-title":"Adv Exp Med Biol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0131848","article-title":"Long-Term Serological Follow-Up of Acute Q-Fever Patients After a Large Epidemic","volume":"10","author":"Wielders","year":"2015","journal-title":"PloS One"},{"key":"B34","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.epidem.2015.07.001","article-title":"Kinetics of Antibody Response to Coxiella Burnetii Infection (Q Fever): Estimation of the Seroresponse Onset From Antibody Levels","volume":"13","author":"Wielders","year":"2015","journal-title":"Epidemics"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/157.4.781","article-title":"Markers of Cell-Mediated Immunity After Vaccination With an Inactivated, Whole-Cell Q Fever Vaccine","volume":"157","author":"Izzo","year":"1988","journal-title":"J Infect Dis"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00613-12","article-title":"Long-Term Immune Responses to Coxiella Burnetii After Vaccination","volume":"20","author":"Kersh","year":"2013","journal-title":"Clin Vaccine Immunol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02469","article-title":"Regulation of the Germinal Center Response","volume":"9","author":"Stebegg","year":"2018","journal-title":"Front Immunol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"20058","DOI":"10.2807\/ese.17.03.20058-en","article-title":"Relation Between Q Fever Notifications and Coxiella Burnetii Infections During the 2009 Outbreak in The Netherlands","volume":"17","author":"van der Hoek","year":"2012","journal-title":"Euro Surveill"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00207","article-title":"Promiscuous Coxiella Burnetii CD4 Epitope Clusters Associated With Human Recall Responses are Candidates for a Novel T-Cell Targeted Multi-Epitope Q Fever Vaccine","volume":"10","author":"Scholzen","year":"2019","journal-title":"Front Immunol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cit132","article-title":"A New Assay: Specific Interferon-Gamma Detection for the Diagnosis of Previous Q Fever","volume":"56","author":"Graves","year":"2013","journal-title":"Clin Infect Dis"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2014.03.008","article-title":"Immunogenicity of the Q Fever Skin Test","volume":"69","author":"Schoffelen","year":"2014","journal-title":"J Infect"},{"key":"B42","article-title":"A Preliminary Comparison of Five Assays for Detecting Past Exposure to Coxiella Burnetii for Use Prior to Human Q Fever Vaccination","author":"Graves","year":"2018","journal-title":"28th ECCMID"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.00333-18","article-title":"Viable Coxiella Burnetii Induces Differential Cytokine Responses in Chronic Q Fever Patients Compared to Heat-Killed Coxiella Burnetii","volume":"86","author":"Jansen","year":"2018","journal-title":"Infect Immun"},{"key":"B44","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.136.12.4525","article-title":"Bacterial Lipopolysaccharide-Induced Interferon-Gamma Production: Roles of Interleukin 1 and Interleukin 2","volume":"136","author":"Le","year":"1986","journal-title":"J Immunol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1006\/jsre.1996.0225","article-title":"Endotoxin Activates T Cell Interferon-Gamma Secretion in the Presence of Endothelium","volume":"63","author":"Tennenberg","year":"1996","journal-title":"J Surg Res"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.165.5.2783","article-title":"Proinflammatory Effects of IL-10 During Human Endotoxemia","volume":"165","author":"Lauw","year":"2000","journal-title":"J Immunol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0103749","article-title":"Diagnosis of Coxiella Burnetii Infection: Comparison of a Whole Blood Interferon-Gamma Production Assay and a Coxiella Elispot","volume":"9","author":"Schoffelen","year":"2014","journal-title":"PloS One"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1006922","article-title":"Genetic Mechanisms of Coxiella Burnetii Lipopolysaccharide Phase Variation","volume":"14","author":"Beare","year":"2018","journal-title":"PloS Pathog"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.701811\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T19:14:31Z","timestamp":1672946071000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.701811\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,28]]},"references-count":48,"alternative-id":["10.3389\/fimmu.2021.701811"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2021.701811","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,28]]},"article-number":"701811"}}